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Mitochondrial bioenergeticsCardiolipin is a unique phospholipid which is almost exclusively located in the inner mitochondrial membrane
where it is biosynthesized. Considerable progress has recently beenmade in understanding the role of cardiolipin
in mitochondrial function and bioenergetics. This phospholipid is associated with membranes designed to gen-
erate an electrochemical gradient that is used to produce ATP, such as bacterial plasmamembranes and innermi-
tochondrial membrane. This ubiquitous and intimate association between cardiolipin and energy transducing
membranes indicates an important role for cardiolipin in mitochondrial bioenergetic processes. Cardiolipin has
been shown to interact with a number of proteins, including the respiratory chain complexes and substrate
carrier proteins. Over the past decade, the signiﬁcance of cardiolipin in the organization of components of the
electron transport chain into higher order assemblies, termed respiratory supercomplexes, has been established.
Moreover, cardiolipin is involved in different stages of the mitochondrial apoptotic process, as well as in mito-
chondrial membrane stability and dynamics. This review discusses the current understanding of the functional
role that cardiolipin plays in several reactions and processes involved inmitochondrial bioenergetics. This article
is part of a Special Issue entitled: Dynamic and ultrastructure of bioenergetic membranes and their components.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Cardiolipin (CL) is commonly referred to as the signature phos-
pholipid of the mitochondria. Among phospholipid species, CL has
interesting chemical and structural characteristics, being highly
acid and having a head group (glycerol) that is esteriﬁed to two
phosphatidylglyceride backbone fragments rather than one, resulting
in a very speciﬁc ultrastructure and role in the mitochondrial function.
The diphosphatidylglycerol structure combined with four acyl chains
gives cardiolipin its dimeric nature, which is unique among phospho-
lipids and results in high speciﬁc conical structure. Cardiolipin is almost
exclusively associatedwithmembranes designed to produce ATP through
the electrochemical gradient generated by the electron transport chain.
Such membranes include the bacterial plasma membrane [1] and the
innermitochondrialmembrane [2,3]. This ubiquitous and intimate associ-
ation between CL and energy-transducing membranes suggests an im-
portant role for CL in mitochondrial bioenergetic processes.
Cardiolipin has been shown to interact with a number of inner
mitochondrial membrane (IMM) proteins, enzymes and metabolite
carriers [4–6]. The list of proteins that bind cardiolipin with high af-
ﬁnity is long and includes, among others, the electron transportc and ultrastructure of bioener-
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ights reserved.chain complexes involved in oxidative phosphorylation (OXPHOS)
and ADP/ATP carrier (AAC) (Fig. 1). Indeed, CL is required for optimal
activity of complex I (NADH–ubiquinone oxidoreductase) [7–9], com-
plex III (ubiquinone–cytochrome c oxidoreductase) [7,10,11], complex
IV (cytochrome c oxidase) [12], and complex V (ATP synthase) [13].
Crystallographic studies have shown the presence of a few tightly
bound CL molecules in each of the crystal structures of complex III
[11], complex IV [14], and ADP/ATP carrier [15] as well as in crystallized
prokaryotic proteins, such as the photoreaction center [16], the trimeric
formate dehydrogenase-N [17] and succinate dehydrogenase [18].
These results suggest that CL is an integral component of these proteins,
the presence of which is critical to folding.
Mitochondrial respiratory chain complexes assemble in higher order
structure referred to generically as respiratory supercomplexes [19–21].
The unique, dimerically cross-linked phospholipid structure of CL seems
to affect the stability and activity of such respiratory supercomplexes. In-
deed, respiratory supercomplexes consisting of complexes III and IV are
destabilized in mitochondria lacking CL [22–24]. Similarly, dimers of
ADP/ATP carrier and other ADP/ATP carrier-containing complexes disso-
ciated in CL-deﬁcient mitochondria [22,25]. These examples illustrate the
important role of CL for mitochondrial bioenergetic function; but in addi-
tion, recent studies are now revealing that CL has amuch broader impact
on mitochondrial physiology and pathophysiology [4–6].
Cardiolipin has been implicated in the process of apoptosis in animal
cells through its interaction with a variety of death-inducing proteins,
including cytochrome c (Cyt c) [26–29]. Cardiolipin-bound Cyt c acts
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Fig. 1. Interaction of CL with oxidative phosphorylation complexes. The electrons are transferred along the path shown in the ﬁgure, resulting in the reduction of oxygen to water at
complex IV. During this process, protons (H+) are pumped by complexes I, III and IV into the intermembrane space to form an electrochemical gradient which is utilized by complex V
to synthesize ATP from ADP and inorganic phosphate (Pi). ATP formed is then transferred by the ADP/ATP carrier (AAC) to the intermembrane space in exchange with ADP. Cardiolipin
binds to complexes I, III, IV, and V and AAC. Q, coenzyme Q; C, cytochrome c; CL, cardiolipin.
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which is an essential step in the release of Cyt c during apoptosis [30].
Another function for CL in relation to energymetabolism is that it anchors
two kinases, mitochondrial creatine kinase and nucleoside diphosphate
kinase to the inner and possibly to outer mitochondrial membrane
(OMM), where they come in contact [31,32].
Due to the role played by CL in mitochondrial bioenergetics as well
as in apoptosis, it is conceivable that CL abnormalities may have impor-
tant implications in mitochondrial dysfunction and hence, in cellular
pathophysiology. Alterations in CL structure, content and acyl chain
composition, associated with mitochondrial dysfunction, have been
described in several pathophysiological conditions, such as hypo–
hyperthyroid states [33–37], heart ischemia–reperfusion [38–42],
nonalcoholic fatty liver disease [43], diabetes [44,45], Barth syn-
drome [46,47] and aging [48–51].
In this review, we discuss the current state of knowledge of the role
played by CL in several reactions and processes involved in mitochon-
drial bioenergetics.
2. Cardiolipin and mitochondrial substrate carriers
The primary function of mitochondria is the synthesis of ATP by ox-
idative phosphorylation. In addition to this important role, these organ-
elles are also the locus of other essential metabolic pathways, such as
the citric acid cycle, fatty acid oxidation, the synthesis and degradation
of amino acids (urea cycle), and the synthesis of iron–sulfur clusters
and heme. To carry out these pathways, metabolites have to be contin-
uously exchanged between the mitochondrial matrix and the cyto-
plasm. The inner membrane contains a mitochondrial carrier family
(MCF) that catalyzes the transport of a number of metabolites between
the intramembrane and matrix space [52]. Deﬁned human diseases are
now known to result frommutations in several members of this family
[52]. One deﬁning feature of the carriers is the so-called tripartite struc-
ture, consisting of three homologous sequence repeats of about 100
amino acid residues each, which was ﬁrst noted in the sequence of the
bovine ADP/ATP carrier [15].
Mitochondrial solute carriers constitute a major part of the inner
membrane proteins. Several studies have shown that CL interacts with
a number of mitochondrial carrier proteins and it is required for their
optimal activity [53]. The mitochondrial phosphate carrier requires CL
for its activity in proteoliposomes, and other phospholipids cannot sub-
stitute for CL [54]. In the heart, oxidation of pyruvate and β-oxidation of
fatty acids are twomajor sources of ATP generation. The transport of py-
ruvate into the mitochondria by the pyruvate carrier and the exchange
of carnitine esters by the carnitine: acylcarnitine translocase are crit-
ical for energy metabolism. The activities of both these translocases,
reconstituted in proteoliposomes, have been shown to bemost efﬁcient
in the presence of CL, and this could not be achieved by other phospho-
lipids [55,56]. The tricarboxylate carrier has been demonstrated to bestimulated in the presence of CL, although the same stimulatory ef-
fect is observed in the presence of other phospholipids, such as
phosphatidylserine and phosphatidylinositol [52]. Facing membrane
lipids consisting of up to 20% CL, it is not surprising that mitochon-
drial carrier proteins interact with CL, this phospholipid being one
of the major lipid components of the IMM. On solubilization of mito-
chondrial carriers, detergents replace to a large extent the membrane
lipids. Without their native environment, the carriers become labile
and the supplementation of phospholipids, especially of cardiolipin,
may protect and facilitate the puriﬁcation of the carrier in a functionally
intact state. Preservation and stabilization of the native state of these
carrier proteins by CL could explain the increased transport activity of
these proteins, when measured in the reconstituted proteoliposomes.
The importance of CL in maintaining the full catalytic activity of these
carrier proteins may result from its unique large head group carrying
two negative charges, requiring a speciﬁc and tightly interacting bind-
ing site, which may stabilize a protein domain in a clamp-like manner.
The ADP/ATP carrier plays an important role in energy metabolism
by allowing the ATP formed by oxidative phosphorylation to pass across
the IMM to intermembrane space. The movement of ATP is coupled by
an antiportmechanism resulting in the 1:1 exchange of ATP for external
ADP. Interestingly, the activity of the AAC has been shown to be optimal
only in the presence of tetralinoleoyl–CL [53]. Other CL species, such as
tetraoleoyl–CL and monolyso–CL, and also other phospholipids, were
not effective in stimulating the AAC activity. There is also evidence
from studies in yeast that absence of CL destabilizes the interaction of
ACC with other mitochondrial proteins [25].
ADP/ATP carrier is themost abundant protein in the IMM (up to 10%
of membrane proteins in bovine heart mitochondria), and this allowed
for a detailed investigation of the carrier–CL interaction at molecular
level. In fact, the availability of large amount of puriﬁed ACC pro-
tein and the strong stabilization of the structure by inhibitor ligand
carboxyactractyloside (CAT), thus preventing protein unfolding and
degradation [57], have allowed for the puriﬁcation of the protein and
its crystallization in the CAT-bound form. The crystal structure demon-
strated that there are either twomolecules of CL bound permonomer of
ACC [15], or threemolecules of CL bound per monomer of ACC [58]. The
additional tightly bound CL found in the second crystal structure seems
to be important in stabilizing protein–protein interactions in the crystal
[15]. In addition to this X-ray structures, parallel 31P NMR measure-
ments have revealed the presence of tight bound CL to AAC [59]. The
tight binding of CL can be rationalized in view of the large excess of pos-
itive charges in the AAC. A number of lysine residues have been sug-
gested to face the lipid bilayer at the level of the membrane surface
[53]. It was proposed that the CL molecules are bound at the lysine res-
idues such that their headgroups face the matrix side. CL has the nega-
tive charges distributed over a large headgroup having two phosphates
separated by glycerol. It is possible that the head group structure of CL
allows it to bind optimally to sites on ACC. From the crystal structure
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hydrogen bonding with main chain nitrogens and with carbonyls of
symmetry-related residues, while the acyl chains of CL interacts with
aromatic or hydrophobic residues. Interestingly, two CLs were localized
at the interface of the adjacent ACC monomers involved in linking the
monomers within a dimer. The phosphate groups are connected to
the matrix short helices and two lysine residues of the opposingmono-
mers. Thus, with the hydrophobic forces of the alkyl chains, CL seems to
provide the glue for the dimer formation. It was proposed that the two
CLs are also involved in the cross talk for the cooperative function of the
monomers [58].
3. Cardiolipin and respiratory chain complexes
3.1. Cytochrome c oxidase
Cytochrome c oxidase (CcO) is a transmembrane protein–
phospholipid complex that consists of 13 subunits with a combinedmo-
lecular weight of 205kDa. Of the 13 subunits of themammalian CcO, the
mitochondrial genome encodes subunits I, II and III, which form the cat-
alytic core of the enzyme [60]. This enzyme complex spans the IMM and
is in contact with 40–60 molecules of membrane phospholipids. Isolated
detergent solubilized bovine CcO commonly contains 20–40mol of phos-
pholipids (phosphatidylcholine, phosphatidylethanolamine, cardiolipin)
per mol of enzyme; however, only CL is known to be tightly bound with
the isolated complex [12,61]. Cardiolipin is not a passive component of
the CcO, but is functionally required for normal electron transport and
proton translocation activity of this enzyme complex. Primarily based
on puriﬁcation and delipidation by chromatography and binding afﬁnity
assays [12,61], two classes of CL binding sites have been deﬁned: two
sites of high afﬁnity and one to two additional sites with a lower afﬁnity.
The latter have been associated with structural integrity of CcO and of its
dimeric form, because these CLs stabilize the subunit VIa and VIb, which
are mandatory for the formation of the dimer. The two CLs binding CcO
with high afﬁnity are structurally and functionally important, and have
been associatedwith the regulation of the electron activity of the enzyme.
In fact, their removal from CcO destabilizes subunits interactions which
are essential for full activity [12,62]. Removal of these CLs decreases
electron-transport activity by around 50%; nearly full electron-transport
activity is restored by the re-association of exogenous CL with CL-free
CcO. Besides inducing activity loss, CL removal destabilizes CcO and spe-
ciﬁc subunits dissociate [62]. The crystal structure of bovine CcO homo-
dimer has been determined to a resolution of 1.8 Å [63]. A combination
of high resolution X-ray structure analysis of integral lipids in bovine
CcO, with mass spectroscopy analysis of their chain lengths and the posi-
tion of the unsaturated bonds of the hydrophobic tails, provides under-
standing of structural and functional roles played by these lipids in the
CcO [64,65]. Thirteen lipids, including two CLs, one PC, three PSs, four
phosphatidylglycerols and three triacylglycerols, were resolved in CcO.
Crystallographic data resolves two unique CL binding sites on CcO. One
CL is bound between subunit VIa on one monomer and subunit III on
the other. The four acyl chains of CL interacts through van derWaals con-
tacts with hydrophobic aminoacid residues belonging to bothmonomers,
and two phosphate groups interacts with both monomers via hydrogen
bond. Thus, the dimeric state of the bovine CcO is primarily stabilized by
CL at subunit VIa. The second CL is located near subunit VIIa and stabilizes
the association between this subunit with subunit I. A third CL (not
resolved in crystal structure of bovine heart CcO) was found by
photolabelling experiments with arylazido-containing CL analogs [64].
This CL is located between subunits VIIa and VIIc near to the entrance
to the putative proton pumping channel, which contains a conserved
aspartate. The authors hypothesized that this CL molecule could poten-
tially function as proton antenna to facilitate proton entry into the chan-
nel, thus explaining the CL requirement for full enzymatic activity.
Very recently, the binding of CL to CcO in a monomeric form was ex-
plored bymeans of coarse-grainmolecular dynamics (CGMD) simulation[66]. This technique has been successfully used to explore the lipid–
protein interplay and more speciﬁcally lipid binding to variety of
membrane proteins. The set of CGMD simulations obtained in this
study, identiﬁed the precise positions of the CL binding sites on CcO.
They agree with and reconcile all known experimental data. Most re-
markably, two of the binding sites were found located at the matrix en-
trance of known proton uptake pathways (D and H) in CcO. In the
context of the ability of CL to trap protons, these data support the notion
that CL optimizes CcO electron transport activity by providing protons to
the uptake pathway.
3.2. Ubiquinol cytochrome oxidoreductase
Complex III (ubiquinol-cytochrome c oxido-reductase), a multi-
subunit protein complex embedded in the IMM, is a central enzyme
in oxidative phosphorylation which catalyzes electron transfer from
membrane-localized ubiquinol to water-soluble cytochrome c. This
redox reaction is coupled to the translocation of protons across the
IMM. Bovine heart complex III is fully active after it is puriﬁed from
mitochondria. The detergent-solubilized enzyme contains a number
of bound CLs which are required for maintenance and stability of the
functional and structural integrity of complex III [10]. Removal of
these bound CLs by phospholipase A2 hydrolysis, destabilizes com-
plex III resulting in an almost complete loss of activity and dissocia-
tion of subunits. Re-association of CL results in the stabilization of the
quaternary structure of this enzyme complex and restoration of its
full activity. This effect could not be replaced by other mitochondrial
phospholipid species. This indicates that CL is either essential for cat-
alytic function of complex III, or that it acts as an allosteric ligand that
stabilizes the fully active conformation of this enzyme complex [10].
Several tightly bound phospholipids, including CL, were identiﬁed in
X-ray structure of yeast complex III, while no bound CLs were detect-
ed in bovine or chicken heart mitochondria [11]. Destabilization of indi-
vidual phospholipid-binding site in yeast complex III by site-directed
mutagenesis, suggests that these phospholipids are important for
structural and functional integrity of this membrane-associated pro-
tein complex, presumably stabilizing its dimeric structure. One CL
molecule is found in a depression of cytochrome b, cytochrome c1 and
Rieske protein closed to the site of ubiquinone reduction. This CL mole-
cule appears to stabilize the architecture of the proton conduction envi-
ronment at this site and may be involved in proton uptake [67]. Several
mutations in this site either reduce electron transfer activity or reduce
stability of associated subunits [68].
3.3. NADH CoQ oxidoreductase
Complex I (NADH-ubiquinone oxidoreductase) is a multisubunit
integral membrane complex of the mitochondrial electron transport
chain that catalyzes electron transfer from the NADH to ubiquinone.
The redox reaction is coupled to proton translocation across the mem-
brane, contributing to proton motive force. Mammalian complex I is a
multi-subunit protein consisting of at least 45 dissimilar subunits with
a total molecular mass of ~980kDa [69,70]. Seven of the complex I sub-
units are mitochondrially-encoded and form the core of the enzyme;
the remainder are nuclear encoded. The activity of this enzyme complex
is considered the rate limiting step for mitochondrial respiratory chain
and, therefore, an important factor in the regulation of OXPHOS process.
Complex I is also considered an important site of superoxide anion gen-
eration in mitochondria [71–73]. Complex I seems to have a functional
and structural requirement for bound phospholipids [7]. However, the
structural and/or functional importance of phospholipids bound to
complex I, especially CL, has not been conclusively demonstrated. Puri-
ﬁed complex I usually has very lowubiquinone reductase activity unless
it contains relatively high amounts of phospholipids, or the phospholip-
id depleted complex I is re-associated with a mixture of phospholipids
that includes CL [7]. Recently, 9 CLs were identiﬁed in puriﬁed bovine
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phosphatidylcholine (PC) per complex [74].
Results from our laboratory have demonstrated that treatment of
bovine heart submitochondrial particles with nonylacridine orange, a
compound that interacts speciﬁcally with CL, resulted in a marked inac-
tivation of complex I and that exogenous added CL fully prevented this
inactivation, while other phospholipids such as PC and PE were ineffec-
tive [8]. In addition, decreased complex I activity in liver mitochondria
isolated from rat fed with a choline-deﬁcient diet, to model in animals'
nonalcoholic fatty liver disease, could also be completely restored to
the level of control liver by exogenous added CL [43]. Under condition
of a choline-deﬁcient diet, the mitochondrial content of CL decreased,
due to the ROS-induced CL oxidation. Although no high-resolution crys-
tal structure of the entire complex I is available, these ﬁndings strongly
suggest the presence of functionally important CLmolecules in the com-
plex I.
3.4. Complex II (succinate dehydrogenase)
Mitochondrial respiratory complex II is a tetrameric enzyme com-
posed of a soluble catalytic heterodimer in thematrix and a heterodimer
of membrane subunits in the IMM. Complex II serves as a link between
the tricarboxylic acid cycle and the electron transport chain. This enzyme
participates in oxidative phosphorylation but not in the proton-gradient
during ATP synthesis. There appears to be no evidence for the association
of CL to complex II. However, in a very recent study, Schwall et al. [75],
using complex II enzymes reconstituted into nanoscale lipid bilayers
(nanodiscs) with varying lipid composition, demonstrated, for the
ﬁrst time, that the phospholipid environment, speciﬁcally the presence
of cardiolipin, is required for optimal stability, assembly and enzymatic
activity of complex II, as well as curtailment of ROS production.
3.5. F0F1 ATP-synthase
The mitochondrial F0F1 ATP-synthase (complex V) is a multisubunit
complex which consists of two functional domains: F1, situated in the
mitochondrial matrix, and F0, located in the inner mitochondrial mem-
brane. Complex V uses the energy created by the proton electrochemi-
cal gradient to phosphorylate ADP to ATP. Complex V contains tightly
bound CL, as demonstrated by characteristics 31P-NMR line broadening
[59]. The CL:F0F1 stoichiometry in the delipidated complex V was 2.5:1.
Whenphospholipids are removed from the F0F1 complex, its activity de-
creases to very low levels, while full restoration of this activity can be
achieved by reconstitution with a variety of phospholipids. Observa-
tionsmade on the catalytic and structural characteristics of this enzyme
complex, indicate that CL is able to inﬂuence properties of this enzyme
more dramatically than the othermajor innermembrane phospholipids
PC and PE [76].
F0F1 ATP synthase has been shown to form dimers [77] as well as
higher oligomeric assemblies [78]. Proposed functional roles of oligo-
meric ATP synthase are stability advantages and an essential role for
cristae formation [79]. Studies of the mitochondrial morphology of
yeast mutants with destabilized ATP synthase dimers, conﬁrmed the
concept that dimeric and oligomeric arrangement of ATP synthase is
involved in determining mitochondrial cristae morphology [80]. Very
recently, Achean et al. [81] employed cryoelectron tomography to com-
pare the structural organization of the complex V in ﬂight-musclemito-
chondria from wild-type, and CL-synthase mutant ﬂies with virtually
complete loss of CL. Their ﬁndings suggest that CL is critical for the de-
gree of oligomerization and the degree of order in these ATP synthase
assemblies, which is likely to affect cristae morphology and energy efﬁ-
ciency. It has been hypothesized that this effect of CL could either result
from direct interaction with the enzyme, or from physical constraints
associated with membrane curvature. Due to its molecular shape, CL is
known to partition into high-curvature membrane segments and to
adopt a speciﬁc orientation with respect to the intrinsic curvature, dueto its inherent anisotropy. Thus, CL and ATP synthase might act in con-
cert to reduce the free energy imposed bymembrane curvature, togeth-
er stabilizing these high-curvature folds [81].4. Cardiolipin and mitochondrial supercomplexes
The mitochondrial electron transport chain (ETC) comprises four
large protein complexes, which along with the F0F1 ATP synthase and
mobile electron carriers (e.g. cytochrome c and coenzyme Q) constitute
themachinery for converting metabolic energy into ATP. Since the con-
solidation of this view of the oxidative phosphorylation system, one
contentious issue has been the nature of its physical organization. The
currently favored view is the “random collision” model, ﬁrst proposed
by Hackenbrock et al. [82] (Fig. 2). According to this model, all compo-
nents of the ETC are distinct entities that can diffuse individually in
the mitochondrial membrane, and the electron transfer depends on the
random transient encounter of the four individual protein of the com-
plexes and the two small mobile electron carriers, CoQ and cytochrome
c. ATP synthase is assumed to diffuse laterally in the membrane. In the
solid-state model, ﬁrst proposed by Chance and Williams [83], the en-
zyme components of ETC are assembled into a large supramolecular
structure and the substrate is channeled directly from one enzyme to
the next.
There is now a growing awareness that the individual components
of the ETC assemble in higher order structure referred to generically
as supercomplex or respirasome [19–21]. Evidence accumulated from
functional and structural studies supports the existence of these supra-
molecular assemblies, which includes oxygen consumption charac-
teristics [19] and metabolic ﬂux analysis [84,85]. Several models of
supercomplexes, involving components of the electron transport
chain (complexes I, II, III and IV), and complex V and ACC carrier,
have been proposed (Fig. 2). By using blue native electrophoresis
after mild solubilization of mitochondria with digitonin, the exis-
tence of two supercomplexes composed by complexes I, III and IV with
a stoichiometry of I1, III2, and IV4, and by complexes III and IV with a stoi-
chiometry of III2 and IV4, was demonstrated [19,86]. Such supercomplex
organization of ETCwould likely increase the efﬁciency of electron/proton
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tion of potentially toxic reactive oxygen species, that have been proposed
to be involved in the pathogenesis of cardiovascular and neurodegenera-
tive diseases. This is consistent with the suggestion that the respirasome
is a dynamic assembly, the aggregation states of which can respond to
variations in the demand for energy under different physiopathological
conditions [19].
Cardiolipin seems to participate in the structural organization and
stabilization of the respiratory chain complexes in high order structure
of functional importance [20,22–25,87]. Because these conclusions were
drawn entirely from electrophoretic studies, it is important to note that
a kinetic study of complex III/IV activity in isolatedmitochondria also sup-
ports a role for CL in supercomplex formation [88]. Recent structural stud-
ies of the puriﬁedmammalian and yeast respiratory ETC supercomplexes
by single particle cryoelectron microscopy [89,90] and cryoelectron to-
mography [91], resulted in three-dimensional density maps of atomic
models for these structures, showing speciﬁc arrangements of individual
complex in the supercomplexes. These studies revealed the presence
of spaces between transmembrane domains of individual complexes
which may by ﬁlled with phospholipids. About 200 CLs were esti-
mated to be present in the puriﬁed bovine respirasome (I1III2IV1),
and about 50 CLs in the III2IV2 supercomplex from Saccharomyces
cerevisiae [89]. This level of CL is in great excess over the amount of
CL associated with the structure of the individual puriﬁed complexes
(see above). The dependence on CL for supercomplex formation was
clearly demonstrated in a recent studybyBazán et al. [92]. By employing a
system composed of puriﬁed CIII and CIV from S. cerevisiae and liposomes
of different phospholipid composition, these authors demonstrated, for
the ﬁrst time, the reconstitution of the supercomplexes III2IV1 and
III2IV2 from individual CIII and CIV in proteoliposomes and speciﬁc de-
pendence of CIII, CIV formation on liposomes containing CL in strong
preference over other phospholipids. Thus, CL seems to be essential
for supercomplex formation in addition to its occurrence as in integral
part of individual complexes.
Recently, with a new dual-afﬁnity tag, AAC was found to participate
in the formation of these supercomplexes composed of one AAC dimer
(ACC)2 and two copies each of complexes III and IV [22]. In yeast mito-
chondria lacking CL, these complexes are absent or less deﬁned, sug-
gesting that CL is required for normal assembly and/or stability of the
respiratory supercomplexes. Possibly, CL acts as a glue between these
protein complexes by intercalating between the transmembrane sec-
tions of the components. The physical association of complexes III and
IV in a supercomplex not only results in the enhanced efﬁciency of elec-
tron ﬂow between these complexes, but also increases their proton-
transporting capacity, thus creating a local microenvironment with rel-
atively high electrochemical gradient. Moreover, CL has been suggested
to functionwith the phosphate head groups as a proton trap, restricting
pumped protons within its head-group domain, providing the structur-
al basis formitochondrialmembrane potential (ΔΨ) and supplying pro-
tons for the ATP synthase [93]. Adjacent to the respiratory proton
pumps, the buffering by CL would increase the voltage component ΔΨ
of the electrochemical gradient within the supercomplex. Therefore, in
addition to connecting proteins and enhancing efﬁciency of electron
ﬂow, CL could locally contribute to creating a high ΔΨ that is needed
to drive the directional ATP export vs ADP import through the AAC
across themitochondrialmembrane [53]. Through facilitating respirato-
ry supercomplex assembly and recruiting AAC2, it has been suggested
that under optimal conditions, CL increases the efﬁciency of OXPHOS
by at least 35% [25].
The question arises how CL is incorporated into these protein com-
plexes andwhich role CL plays in the overall process of complex assem-
bly. The fact that many structurally unrelated proteins are able to
engage in a strong binding with CL suggests that the structure of this
phospholipid must provide a ﬂexible force ﬁeld that can adapt to a va-
riety of protein surface. Further insight into the nature of CL–protein in-
teractions may be derived from crystal structure. X-ray crystallographyhas been used to examine the structural details of an interaction be-
tween CL and the photoreaction center, a key light-driven electron
transfer protein complex found in the Rhodobacter sphaeroides, where
CL was for the ﬁrst time resolved [16]. X-ray diffraction data showed
that binding of CL to the protein involved a combination of strong hy-
drophilic interactions between the polar head group of CL with a num-
ber of aminoacid residues of the protein, involving electrostatic forces,
hydrogen bonds and water molecules. Essential in these interactions
is the ability of the phospholipid to ﬁll cavities and grooves between hy-
drophobic interfaces of the protein located with the membrane bilayer,
while providing speciﬁc ionic bridges at the water hydrophobic interface.
Cardiolipin with unsaturated fatty acids is especially suited for this role
with four twisted hydrocarbon domains and negatively charged hydro-
philic domain [94].
5. Cardiolipin interaction with mitochondrial kinases
Another important role for CL in energy metabolism is to anchor two
very large kinases, mitochondrial creatine kinase (mtCK) and nucleoside
diphosphate kinase (NDPK) to the mitochondrial membranes [31,32].
Both mtCK and NDPK are located in the intermembrane/cristae space. In
muscle and brain, creatine kinase provides a reserve supply of high ener-
gy phosphate (creatine phosphate) during initial signal period when the
ATP is rapidly consumed. The evidence for the involvement of these two
kinases in mitochondrial bioenergetics comes from the fact that they
bind to voltage dependent anion channel (VDAC) and ATP/ADP exchange
protein [32]. Both mtCK and NDPK fulﬁll two main functions, the func-
tional coupling to inner membrane AAC and mitochondrial respiration,
and the lipid transfer between membranes. A quantitative analysis of
the properties ofmtCK, in comparisonwith X-ray structure, shows the at-
tachments with CL [95]. The structural basis and functional consequences
of the CL interactions with mtCK and NDPK have been studied in detail
and discussed in a recent review [96]. They mainly result in a functional
interaction of mtCK and NDPK with the AAC, probably by forming
proteolipid complexes in the IMM. These interactions allow for an ex-
change ofmetabolites, including ADP and ATP, between themitochondri-
almatrix space and the cytosol, which ultimately regulatesmitochondrial
respiration. In addition, both mtCK and NDPK promote the transfer of
lipids, including cardiolipin, between model membranes. This property
may have important implications for apoptosis because it is known that
cardiolipin moves from the inner to the outer mitochondrial membranes
during apoptosis, and that this phospholipid provides a recognition site
for Bcl2 proteins, notably t-Bid, to bind to mitochondria and promote
the apoptotic process [96].
Interactions between components of the inner and the outer mem-
brane are necessary for a number of central mitochondrial functions
such as the channeling of metabolites, coordinated fusion and ﬁssion
of mitochondria, and protein transport. Some of these interactions ap-
pear stable such as the so-called morphological contact sites. Both CL
and PE appear to constitute the twomajor phospholipids presentwithin
the contact sites. A role for mtCK in the formation and stabilization of
contact sites has been suggested. Epand et al. [96] described an interac-
tion between the octameric ubiquitous form of mtCK and CL which po-
tentially induced the lipid phase separation of CL into discrete domains
in vitro. Within the contact sites, mtCK may bind to CL on the IMM and
VDAC on the OMM to form a bridge across the bilayer of the mitochon-
dria, which stabilizes the CL enriched contact sites. Thus, the interaction
betweenCL andmtCKmay have important implication for the apoptotic
process.
6. Cardiolipin oxidation and ETC complexes
It is estimated that approximately 0.2–2% of the oxygen taken up by
a cell is converted by mitochondria to ROS [97]. Within mitochondria,
the electron transport chain is considered the main source of ROS. The
primary ROS generated into the mitochondria is O2•−, which is then
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by superoxide dismutase (SOD). Hydrogen peroxide, in turn, is broken
down into water by glutathione peroxidase or catalase; if this does not
occur, H2O2 can undergo Fenton's reaction in the presence of divalent
cations such as iron to produce hydroxyl radical (•OH), which can be
even more harmful to the mitochondrial biomolecules. The sites of su-
peroxide anion production along the respiratory chain have been the
subject of many studies [for a recent review see 98]. The two major
sites of O2•− production are complex I and complex III. Mitochondria
can produce superoxide anion, predominantly from complex I, when
the matrix NADH/NAD+ ratio is high, leading to a reduced FMN site
on complex I, and when they are not producing ATP and consequently
have a high proton-motive force and a reduced coenzyme Q pool, lead-
ing to reverse electron transport. Based on inhibitor studies in heartmi-
tochondria, the site of superoxide production at complex III is probably
the unstable ubisemiquinone molecules [99] or cytochrome b [100]. It
should be acknowledged that ROS are also produced to a lesser extent
outside of the mitochondrion.
Cardiolipin molecules are particularly susceptible to ROS-
induced oxidation, either for their fatty acyl composition or for
their proximity to the ROS generating centers. In fact, CL molecules are
rich in unsaturated fatty acids, particularly linoleic acid in heart and
liver, or docosahexanoic and arachidonic acids in brain tissue mitochon-
dria. In addition, CLmolecules are located near to the site of ROSproduc-
tion,mainly represented by complex I and complex III of the respiratory
chain. The presence of a methylene bridge between two double bonds
of CL fatty acids renders these compounds sensitive to ROS-induced
oxidation.
As mentioned above, CL molecules are required for functional activity
of a number of inner mitochondrial membrane proteins, including respi-
ratory chain complexes involved in OXPHOS. Thus, oxidative damage to
CL may have deleterious effect on respiratory chain complex activity
and mitochondrial function. Indeed, exposure of bovine heart submito-
chondrial particles to ROS generating enzymatic systems, resulted in a
marked inactivation of complexes I, III, and IV, associated with a parallel
oxidation/depletion of mitochondrial CL [8,101,102]. These alterations
in ETC complex activity and in mitochondrial CL content were abolished
by the addition of SOD+ catalase. Interestingly, exogenously added CL-
liposomes almost completely prevented the ROS-mediated loss in the ac-
tivity of these respiratory chain complexes, while other phospholipids
such as PE and PC and oxidized CL were unable to prevent this effect.
Thus, the observed ROS-mediated defects in mitochondrial complex
I, III and IV activity could be ascribed to ROS-induced CL oxidation/
depletion. The exact mechanism by which CL oxidation affects the
activities of these enzyme complexes is not well known. However,
regarding CL oxidation-induced complex IV inactivation, destabiliza-
tion of functional important subunit interactions and/or CL-
hydroperoxide mediated peroxidation of key aminoacid residues,
particularly tryptophans, has been suggested [103].
In addition to affect the activity of individual ETC complexes,
ROS-induced CL oxidation may also affect OXPHOS supercomplex
formation and/or stabilization. It was demonstrated by ﬂux control
analysis that the maintenance of a I–III supercomplex, after
reconstitution of a protein fraction enriched with complex I
and complex III into phospholipid vesicles at high protein to lipid
ratios, is abolished if lipid peroxidation is induced by 2,2′-azobis-
(2-amidinopropane) dihydrochloride (AAPH) before reconstitu-
tion [104]. Evidently, the distortion of the lipid bilayer induced by
peroxidation and the alteration of the tightly bound phospholipids,
determine the dissociation and destabilization of the supercomplex
originally present in the lipid-poor preparation. Cardiolipin oxidation/
depletion might have a primary role in this effect. Consistent with
this, destabilization ofmitochondrial respiratory chain supercomplexes,
due to CL alterations, has been reported in Barth syndromepatients, and
thismay have important implications in the pathogenesis of this disease
[105].7. Cardiolipin and MPTP
Mitochondrial permeability transition pore (MPTP) is deﬁned as the
sudden increase of mitochondrial inner membrane permeability to low
molecular weight solutes (1.5kDa) in response to many stimuli, includ-
ing high levels of Ca2+ and oxidant stress. Opening of the MPTP by a
combination of abnormally elevated intramitochondrial Ca2+ and oxi-
dative stress induces the collapse of transmembrane ion gradients,
resulting in membrane depolarization and uncoupling of oxidative
phosphorylation [106]. With reduced ATP levels, the cells cannot
maintain structural and functional integrity, including ion homeostasis,
resulting in irreversible damage and cell death, predominantly through
necrosis. A number of molecules were accepted as key structural compo-
nents of the MPTP, including, Cyp-D in the matrix, AAC and phosphate
carriers in the inner membrane and VDAC (also known as porin) in
the outer membrane [106–108]. Very recently, it was reported that
reconstituted dimers of the F0F1 ATP synthase, incorporated into lipid
bilayers, form Ca2+-activated channels with properties identical to
those of the mitochondrial megachannel, the electrophysiological
equivalent of the MPTP [109], indicating dimers of the FoF1 synthase
as a new putative component of the MPTP.
Ca2+ ions are themost prominent inducers of theMPTP. Our studies
have shown that exogenous added oxidized CL sensitizedmitochondria
to Ca2+-induced MPTP opening [110]. Similarly, oxidation of endoge-
nous CL by tert-butyl hydroperoxide, resulted in MPTP opening [111].
This synergistic effect of Ca2+ and oxidized CL on MPTP opening sug-
gests that both these compounds could play a coordinated role in this
process by interacting with components of the MPTP, probably AAC.
Cardiolipin molecules were shown to be tightly associated with AAC
with a stoichiometry of three CLs per protein monomer [59]. It was
also suggested that interaction between two monomers of the AAC is
mediated by CLs, which could stabilize the dimeric structure by control-
ling the conformational changes, and participate in triggering a concerted
ADP/ATP exchange [58]. Oxidized CL would destabilize the appropriate
conformation of the AAC, favoring a conformation of this protein for
MPTP opening. Bivalent cation Ca2+ could be involved in this transition.
Indeed, it was proposed by Brustovetsky and Klingenberg [112] that the
bivalent cation Ca2+, due to its high afﬁnity for complexing CL, interferes
with the interaction of AAC and CL, with a resultant structural change in
AAC and its transition to a channel. It was also shown, in a study of AAC
containing liposomes, that oxidized CL reversibly and competitively in-
hibits the activity of ANT [113]. Interestingly, the induction ofMPTP open-
ing by oxidizedCL andCa2+ is associatedwith the release of cytochromec
frommitochondria [110]. The synergistic effect of Ca2+ and oxidized CL in
the induction of MPTP opening and in the release of cytochrome c from
mitochondria (Fig. 3) may have important implications in cell death, as
well as in those physiopathological situations characterized by alterations
in Ca2+ homeostasis and accumulation of oxidized CL in mitochondria,
such as aging [48–50], heart ischemia/reperfusion [38,40,42,114] and
other degenerative diseases. Thus, compounds able to prevent CL oxida-
tion in mitochondria may open new perspectives for treatment of these
disorders. There is continued interest in discovering new antioxidants or
free radical scavengers of high potency and low toxicity that are effective
in preventing CL oxidation in mitochondria. Among these compounds,
melatonin [115] and plastoquinones [116,117] have been shown to be
particularly effective in preventing CL oxidation in mitochondria by ROS
attack. This would explain, at least in part, the protective effect afforded
by these antioxidants against some pathophysiological situations and
aging [118,119].
8. Interaction of cardiolipin with cytochrome c
Cytochrome c is a nuclear-encoded mitochondrial protein that is in-
volved in life and death decisions of the cell. It participates in electron
transfer of the ETC and it is, thus, an indispensable part of the energy
production process. Cyt c also functions as a radical scavenger within
ROS
Ca2+
IMM
OMM
ETC
AAC
CLox
CLox
CL
Cyt c
Cyt c
Cyt cCyt c
Fig. 3. Role of oxidized cardiolipin in the release of cytochrome c frommitochondria. ROS
production causes cardiolipin oxidation which, in turn, promotes cytochrome c detach-
ment from the IMM. Cytochrome c is then released into the cytosol through OMM, via
MPTP or Bax/Bak oligomerization (for details see the text). OMM, outer mitochondrial
membrane; IMM inner mitochondrial membrane; ETC, electron transport chain; AAC,
ADP/ATP carrier; CL, cardiolipin; CLox, oxidized cardiolipin, Cyt c, cytochrome c.
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oxide, thus regenerating O2 [120]. In addition, Cyt c plays a crucial role
in the regulation of apoptotic process [28,29]. In fact, its release frommi-
tochondria appears to be a central event in the induction of the apopto-
tic cascade that ultimately leads to programmed cell death.
Interactions between Cyt c and CL are an important determinant of
apoptosis. Cytochrome c interactswith CL through two separate binding
sites termed the A-site and C-site [28,121]. The A-site most likely in-
volves weak electrostatic interactions between the phosphate groups
of CL and lysine residues of Cyt c [122] and participates in the electron
transfer and radical scavenging functions of Cyt c. The A-site is reversible
and easily displaced by ATP or by increasing ionic strength. The C-site is a
more stable interaction involving hydrophobic interactions and hydrogen
bonding between one of the polyunsaturated acyl chains of CL and Asn52
residue of Cyt c. It has been suggested that one of the acyl chains of CL ﬁts
into a pocket of Cyt c, while the other three acyl chains remain in the
membrane [121]. An alternative hypothesis suggests an interaction of
two fatty acyls of CL with Cyt c [123]. The binding results in both partial
unfolding and conformational changes of the Met-80 heme iron interac-
tion, as well as spectral changes in the heme iron spin state [121,123].
The A-site interaction essentially tethers Cyt c to the membrane. Kagan
et al. [30] found that CL bound cytochrome c acts as a peroxidase capable
of catalyzingH2O2 dependent peroxidation and that CL oxidation is essen-
tial step in the release of cytochrome c during apoptosis. CL stimulates the
peroxidase activity of cytochrome c by destabilizing the tertiary structure
of this hemeprotein through the hydrophobic interaction, a process
which is further enhanced by increases in the degree of CL unsaturation
[124].
Besides to its role in promoting Cyt c release from mitochondria, CL
modulates other steps of the apoptotic program. It has been demonstrat-
ed that CL in the OMM provides an anchor and activating platform for
caspase-8, which is processed and translocates to mitochondria upon
Fas receptor activation [125]. Activation of caspase-8 results in the cleav-
age of Bid (a BH-3 only protein) to a truncated form t-Bid which translo-
cates to the OMM and induces the oligomerization of the proapoptotic
proteins Bax and/or Bak (Fig. 3). Electron tomography studies showed
that t-Bid interacts with mitochondria speciﬁcally at the inner and outer
membrane contact sites,which are rich inCL [126]. Cardiolipin-richmem-
branesmay adopt a non-bilayer hexagonalHII conﬁguration at the contact
sites, enabling access of CL to the cytosolic site ofmitochondria.Moreover,
the binding of t-Bid to mitochondria, by directly altering membranecurvature, may play critical roles in other apoptotic-associated processes
such as cristae remodeling [127,128], and mitochondrial fragmentation
[129]. Recruitment of t-Bid into a lipid microdomain of the OMM, most
likely through CL binding,may be necessary for formation ofmultiprotein
complexes which regulate changes in mitochondrial morphology.
Prior the release of cytochrome c from the mitochondria during ap-
optosis, a redistribution of CL occurs from the IMM to the OMM [130].
Here it participates in the formation of cytochrome c/CL peroxidase
complexes and, after CL peroxidation, the formation of the MPTP which
facilitates release of cytochrome c and other proapoptotic factors [110].
Thus, the depletion and remodeling of CL, the generation of ROS and CL
peroxidase capability of cytochrome c, appear to play a coordinate role
for an efﬁcient release of cytochrome c from inner mitochondrial space
[29,131].
9. Conclusions
Cardiolipin has pleiotropic roles in mitochondrial function. The ex-
ponential increase of articles on CL provide impressive evidence for
the new interest in this subject. This review highlighted the role of CL
in mitochondrial bioenergetics. Cardiolipin interacts with a number of
proteins and enzymes involved in fundamental mitochondrial bioener-
getic processes, such as respiratory chain complexes, mitochondrial
substrate carriers and is required for their optimal activity. In addition,
CL appears to play a role in the organization and stabilization of the
OXPHOS complexes and AAC in supercomplexes, which may result in
a more efﬁcient electron/proton ﬂux and hence, ATP synthesis. Thus,
CL is crucial formitochondrial oxidative phosphorylation and for correct
function and structure of the IMM. How CL is incorporated into these
protein complexes, how it modulates the activity of these proteins and
which role CL plays in overall process of complex assembly, are ques-
tions for which a satisfying explanation has yet to be found. Elucidating
the mechanism whereby CL mediates these activities remains an excit-
ing area of future investigation. Cardiolipin is also emerging as an im-
portant player in the regulation of several of the mitochondrial steps
in cell death and mitochondrial membrane stability and dynamics, in-
cluding fusion and ﬁssion processes. Cardiolipin contains unsaturated
fatty acyl chains which are readily oxidizable targets. Peroxidation of
CL is now considered an important event in mitochondrial dysfunction
in cellular pathophysiology and also an early step in apoptotic cell
death. Abnormalities in CL content, fatty acyl chain composition and re-
modeling appear to be, at least in part, responsible for mitochondrial
dysfunction associated with several pathophysiological situations,
including hypo–hyperthyroid states, heart ischemia/reperfusion, heart
failure, diabetes, Barth syndrome, as well as aging and age-related
cardiovascular and neurodegenerative disorders. Pharmacological
strategies designed to prevent CL oxidationmay open new perspectives
for treatment of these disorders.
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